These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 21718251)

  • 1. Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases.
    Serviddio G; Romano AD; Cassano T; Bellanti F; Altomare E; Vendemiale G
    Curr Pharm Des; 2011; 17(20):2036-55. PubMed ID: 21718251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxidative stress and aging.
    Romano AD; Serviddio G; de Matthaeis A; Bellanti F; Vendemiale G
    J Nephrol; 2010; 23 Suppl 15():S29-36. PubMed ID: 20872368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondrial medicine for aging and neurodegenerative diseases.
    Reddy PH
    Neuromolecular Med; 2008; 10(4):291-315. PubMed ID: 18566920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria-targeted peptide antioxidants: novel neuroprotective agents.
    Szeto HH
    AAPS J; 2006 Aug; 8(3):E521-31. PubMed ID: 17025271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioenergetics and mitochondrial dysfunction in aging: recent insights for a therapeutical approach.
    Romano AD; Greco E; Vendemiale G; Serviddio G
    Curr Pharm Des; 2014; 20(18):2978-92. PubMed ID: 24079772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mitochondrial biogenesis: pharmacological approaches.
    Valero T
    Curr Pharm Des; 2014; 20(35):5507-9. PubMed ID: 24606795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Mitochondria as the target for neuroprotectors].
    Shevtsova EF; Kireeva EG; Bachurin SO
    Vestn Ross Akad Med Nauk; 2005; (9):13-7. PubMed ID: 16250325
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New therapeutic activity of metabolic enhancer piracetam in treatment of neurodegenerative disease: Participation of caspase independent death factors, oxidative stress, inflammatory responses and apoptosis.
    Verma DK; Gupta S; Biswas J; Joshi N; Singh A; Gupta P; Tiwari S; Sivarama Raju K; Chaturvedi S; Wahajuddin M; Singh S
    Biochim Biophys Acta Mol Basis Dis; 2018 Jun; 1864(6 Pt A):2078-2096. PubMed ID: 29551729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.
    Calabrese V; Lodi R; Tonon C; D'Agata V; Sapienza M; Scapagnini G; Mangiameli A; Pennisi G; Stella AM; Butterfield DA
    J Neurol Sci; 2005 Jun; 233(1-2):145-62. PubMed ID: 15896810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma membrane redox enzymes: new therapeutic targets for neurodegenerative diseases.
    Hyun DH
    Arch Pharm Res; 2019 May; 42(5):436-445. PubMed ID: 30919268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of Bioactive Compounds in the Regulation of Mitochondrial Dysfunctions in Brain and Age-Related Neurodegenerative Diseases.
    Kessas K; Chouari Z; Ghzaiel I; Zarrouk A; Ksila M; Ghrairi T; El Midaoui A; Lizard G; Kharoubi O
    Cells; 2022 Jan; 11(2):. PubMed ID: 35053373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial mechanisms of estrogen neuroprotection.
    Simpkins JW; Dykens JA
    Brain Res Rev; 2008 Mar; 57(2):421-30. PubMed ID: 17512984
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of mitochondrial ROS in the aging brain.
    Stefanatos R; Sanz A
    FEBS Lett; 2018 Mar; 592(5):743-758. PubMed ID: 29106705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quercetin attenuates neuronal death against aluminum-induced neurodegeneration in the rat hippocampus.
    Sharma DR; Wani WY; Sunkaria A; Kandimalla RJ; Sharma RK; Verma D; Bal A; Gill KD
    Neuroscience; 2016 Jun; 324():163-76. PubMed ID: 26944603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic potential of N-acetylcysteine in age-related mitochondrial neurodegenerative diseases.
    Banaclocha MM
    Med Hypotheses; 2001 Apr; 56(4):472-7. PubMed ID: 11339849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Precision Small-Molecule Proneurotrophic Therapies for Neurodegenerative Diseases.
    Janssens J; Lu D; Ni B; Chadwick W; Siddiqui S; Azmi A; Etienne H; Jushaj A; van Gastel J; Martin B; Maudsley S
    Vitam Horm; 2017; 104():263-311. PubMed ID: 28215298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases.
    Lin MT; Beal MF
    Nature; 2006 Oct; 443(7113):787-95. PubMed ID: 17051205
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin prevents glutamate-induced oxytosis in the HT22 mouse hippocampal cell line through an antioxidant effect specifically targeting mitochondria.
    Herrera F; Martin V; García-Santos G; Rodriguez-Blanco J; Antolín I; Rodriguez C
    J Neurochem; 2007 Feb; 100(3):736-46. PubMed ID: 17263795
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired quality control of mitochondria: aging from a new perspective.
    Weber TA; Reichert AS
    Exp Gerontol; 2010 Aug; 45(7-8):503-11. PubMed ID: 20451598
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.